CEO: Alexei Mlodinow, MD

Visit Website

SIA is developing next-generation products for surgical reconstruction, including the fully re-absorbable mesh with initial use in breast reconstruction surgery. SIA’s mesh “bra” is intended to bridge the muscle gap during post-masectomy recovery.

The biologic mesh currently used for mastectomies results in complications approximately 10% of the time, resulting in thousands of potentially serious bacterial infections that require intervention.

SIA’s DuraSorb® mesh provides a cheaper and safer solution, which can improve the recovery of hundreds of thousands of women worldwide.